shycocan a significant step in the stop transmission of

25
SHYCOCAN a significant step in the stop transmission of COVID- 19 virus in closed spaces & help restart businesses globally VIRUS ATTENUATION DEVICE 2020 October 1 CORPORATION

Upload: others

Post on 07-Jan-2022

1 views

Category:

Documents


0 download

TRANSCRIPT

SHYCOCAN a significant step in the stop transmission of COVID-

19 virus in closed spaces & help restart businesses globally

VIRUS ATTENUATION DEVICE

2020 October 1

C O R P O R A T I O N

The COVID-19 pandemic has had an unprecedented impact on human health and livelihood

21 October 2020

§ 213 countries impacted§ 33.8m infections, 1.01m Fatalities as on 1 Oct 2020 & rising§ Global recession§ Most sectors of economies impacted§ Lack of cure in sight § Recurring with multiple waves§ Widespread fear and uncertainty§ Likely future pandemics of different variant

The biggest challenge of this virus is its infectivity or virulence

The highest risk of transmission is in indoor environments, leading to large scale lockdown of businesses thereby impacting

livelihoods globally

31 October 2020

Breaking the transmission chain requires focused work on these indoor environments

Introducing a new product category “Virus Attenuation Device” for closed spaces

4

Attenuation

the process by which a virus, bacterium, etc., changes

under specific conditions to become harmless or less

virulent.

Disables the Infectivity of the Coronavirus, without

killing it (Surprised!!)

Ashley Coutinho

Shycocan is a path breaking certified product based on the PMEE* technology (protected as a trade secret by the inventor)

Introducing Scalene HyperchargeCorona Canon (SHYCOCAN), adevice that makes the enclosedspace like hospitals, hotels,restaurants, offices, public places,auditoriums etc. safe and preventsits transmission by 99.9% withoutany negative impact to the humansor the environment in any way. Itwas tested for Bacteria, Virus andFungi and found to be only effectiveon S-Protein based viruses.

2020 October 1

All key tests for its safety and effectiveness parameters have been conducted by reputed global laboratories

Product approvals

CEEU – Class I

Based on US FDA’s guidance the Shycocan will currently be marketed under the “Enforcement Discretion Guidance” during the COVID-19 Pandemic/ Public Health Emergency in the US

*PMEE – Photon Mediated Electron Emission

Confirmation of EU, guidance under FDA and Safety tests conducted

YsrumClassification: Class I

Type of equipment: Scalene Hypercharge Corona Cannon.

Brand Name / Trademark SHYCOCANru

Type/Model: SHCC-915

Applicant Scalene Cybernetics Limited.

Declaration of Conformity

(€

Intended Use: The device Scalene Eypercharge Corona Canon (SHYCOCAN) is intended to be used in anindustrial / commercial environment and is designed for active containment by attenuation of Corona familyof viruses. (Laboratories de f,specialidades Immunological S.A. de C.V, Report No: 44527- VirucidalActivity concludes 99.9% virus elimination, dated June 16, 2020). SHYCOCAN operates ona110D40Y

- 50/60 Hz to generate extra high tension at a switching frequency of 20 KHz that delivers the necessarysignals to a photon mediated electrons emitters (PMEE), that produces hypercharge high velocity elechonsthat interacts with the negative seeking S-protein of Corona family of viruses thus reducing infectivity andprevent air and surface borne transmission of Corona family of viruses. The Device utilizes viable biologicalcomponents in the corona family of viruses for its intended purpose @xample: S- protein of the viral Spine).The device does not produce harmful ozone gas (SSTx LLC, Report No: SHY-OZ-05072020, Test No:SHY-2306-50-1, issue date May 16,2024.)

The following harmonized European standards have been applied:

o 20l4l30lBU - Elecfomagnetic Compatibility Directiveo 20l4l30lBU - Low Voltage Directiveo IEC 60335-l:2010, CORI:2010, COM:201l, AMDI:2013, COR1:2014, ANID2:2016, CORI:2016o tEC 61326-l:2012Including amendments by the CE Mmking Directive 93168/EEC.

The CE Marking on the products andlor their packaging signifres that Scalene Cybernetics Limitedholds the reference technical file available to the European union authorities.

Place and Date of Issue: S-Card Campus, Seegehalli Main Road, Bangalore -560 049 I Jwe26,2020.

Authorized Signatory: Name: Dr. Rajah Vijay KumarTitle: Director and Chief Scientific Offrcer

71 October 2020

Form 7.5-1-4-8, Rev. 2

Emergo Global Consulting

2500 Bee Cave Road Building 1, Suite 300 Austin, Texas 78746

UNITED STATES +1 512 327 9997

July 20, 2020 Shreis Scalene Therapeutics LLC 11516 Darnestown Road Gaithersburg, MD 20878 USA Attn: Meena Augustus The Scalene Hypercharge Corona Canon (Shycocan) has been submitted to the FDA via their Emergency Use Authorization (EUA) program for the COVID-19 public health emergency under PEUA201273. The FDA deprioritized review stating:

“Please know that FDA is committed to doing everything possible to help combat the COVID-19

outbreak and appreciated your efforts to make your product(s) available. To help such efforts,

FDA issued an immediately in effect guidance on March 29, 2020, “Enforcement Policy for

Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-

19) Public Health Emergency”.[1] The Scalene Hypercharge Corona Canon may fall under one of

the policies set forth in this guidance, and be distributed without compliance with certain

regulatory requirements as outlined in the guidance.”

The guidance that the FDA references allows certain products to be placed on the US market during the public health emergency under enforcement discretion, waiving certain normal requirements, including a premarket submission, establishment registration, product listing, and unique device identification (UDI). The FDA does not intend to object to the distribution and use of products within the scope of the guidance document, such as air purifiers, intended to be effective at killing the SARS-CoV-2 virus provided certain conditions are met. Once these conditions are met, it is Emergo’s understanding based on the FDA statements that this device may be put on the market during the public health emergency. Kind regards,

Sarah Fitzgerald EMERGO by UL | Senior Consultant, Quality and Regulatory Affairs www.emergobyul.com

[1] https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-sterilizers-disinfectant-devices-and-air-purifiers-during-coronavirus-disease

Aug 13th 2020 To, SCALENE CYBERNETICS LIMITED, S- Card Campus, Seegehalli Main Road, Virgonagar Post, Bangalore -560 049. Sub: SHYCOCAN – Summary of Test Report We hereby acknowledge that the device SHYCOCAN has been tested under the following standards, and reports were released with appropriate document numbers as mentioned below.

1. Household and Similar Electrical Appliances – Safety – Part 1 General Requirements - IEC 60335 1:2010, COR1:2010, COR2:2011, AMD1:2013, COR1:2014, AMD2:2016, COR1:2016. - Report No: 4789499873, Date of Issue: 26.06.2020

2. Electrical equipment for measurement, control and laboratory use – EMC requirements – Part 1: General Requirement - IEC 612326-1

Edition 2.0:2012. - Report No: 4789460695-NABL-S1, Project Number: 4789460695 ULR No: TC61682030000215F. Date of Issue: 29 April 2020.

a) CISPR 11 – Conducted Disturbance / Radiated Disturbances b) IEC 61000-3-2 – Harmonics current emissions. c) IEC 61000-3-3 – Voltage fluctuations and flicker emissions. d) IEC 61000-4-2 – Electrostatic discharge. e) IEC 61000-4-3 - Radiated RF disturbance. f) IEC 61000-4-4 – Electrical fast transient. g) IEC 61000-4-5 – Surge immunity. h) IEC 61000-4-6 – Immunity to conducted disturbance. i) IEC 61000-4-8 – Power frequency magnetic field. j) IEC 61000-4-11 – Voltage dips & short interruptions.

For UL India Pvt Ltd Karthik Venkataraman

Business Manager Life & Health Sciences Division [email protected]

EU CE Class-I Declaration of Conformity

Confirmation of Sale under FDA’s Enforcement Discretion guidance

Confirmation letter for safety tests conducted by UL

91 October 2020

How does COVID-19 virus infect the human body

Spike Protein of the COVID-19 virus

ACE2 Receptor

SARS-COV2Positive Sense Virus Human Cell Wall with

Negative Membrane Potential

SARS-COV2 virus attaching itself to the receptor to injects its RNA and infect the human cell

How Shycocan works to attenuates the SARS-COV2 virus?

101 October 2020

Photons

Electron Cloud

Step 1Shycocan produces high intensity photons

Step 2High intensity photons strike solid surfaces like tables, chairs, walls etc in the room and emit electrons

Solid Surfaces

Step 3Due to continuous operation an electron cloud gets formed in the enclosed room

Step 4The electrons get attached to the SARS-COV2 virus in the environment and neutralizing its positive charge, preventing it from infecting another person. This process is called “Attenuation”

Step 1 Step 2 Step 3

Step 4

SHYCOCAN provides far greater protection and safety than any other method

→ Unobtrusive

→ Safe

→ Continuous

→ Silent

→ Sure

Benefits of SHYCOCAN On all parameters, SHYCOCAN outperforms its peers

SHYCOCAN Air Ionizers Ultraviolet Sprays

Effectiveness 99.9% effective against COVID-19 Not Effective Effective for one-

time disinfectingEffective for a limited period

Utility Continuous functioning

Continuous functioning

Disinfecting per use

Disinfecting per use

Side Effects No side Effects Produces Ozone that harms

Exposure is very harmful to humans

Toxic to humans

Effect Both Air Borne and Surface Only Airborne Both Airborne and

Surface Only for Surface

Conditions All conditions Only for small rooms

Only empty areas using robots

Not used in restaurants etc.

SizesMultiple products can used for all sizes

Only for small spaces

Only for empty spaces Used across sizes

ConsumablesOne time installation - no consumables

Filters need to change, constant maintenance

Cumbersome in regular use

Replenishment of sprays

2020 October 1

SHYCOCAN's effective operational parameters allow for easy installation and wide use→ A single device when mounted

has an effective coverage area of 1000 Sq Ft. (10K cubic feet) and 2nd model of 10K Sq Ft. (100K cubic feet) to be launched later

→ Multiple Shycocan devices may be installed to cover a larger indoor space

→ In the presence of Shycocan, anyone touching a previously infected surface will not contract the virus as it would have been attenuated.

→ The device has no side effects and does not generate ozone like air ionizers. Photons only split on reaction to the solid surface and just pass through gas

→ The metal generating photons does not deteriorate. Hence the device has a long lifespan and requires minimal servicing.

A 100 M2 / 1000 Ft2

Medical facility typically needs 1 device

A 1000 M2 / 10,000 Ft2 ICU

typically needs 10-12 devices

A 1500 M2 / 15000 Ft2

convention centretypically needs 15-18 devices

A 100 M2 / 1000 Ft2classroom typically needs 1 device

A 300 M2 / 3000 Ft2

office plate needs 3-4 devices

A 200 M2 / 2,000 Ft2 restaurant

lounge typically needs 2-3 devices

2020 October 1

SHYCOCAN has significant and immediate demand across market segments

Large application set

of market segments

Healthcare

> Hospitals> Clinics and Dispensaries> Quarantine Centers

Government

> All government buildings incl. executive and judiciary

Industrial

> All manner and mode of worksites

Social Infrastructure

> Restaurants / Pubs> Hotels / Clubs> Movie theatres> Religious congregation places

Education

> Schools> Colleges / Institutes

Retail

> Shops> Malls

Large Transportation Hubs

> Train stations> Airports

Households / Residential

> Critical care rooms for elderly> Senior care> Hostels

→ Each of the segments is a very large market in itself

→ We have based our market view on the need and criticality of the market segment

→ We also believe that this will become a standard offering in most places (akin to air-filters or air-conditioners or security cameras)

→ Even with the advent of a drug (which for mass deployment still looks like many years if not decades away), we don’t see the market shrinking.

2020 October 1

Corona & Influenza family of viruses Attenuated by Shycocan

142020 October 1

Due to the specific action of the Shycocanon the Spike Protein (S-Protein), it works onthe Corona and Influenza family ofviruses (enveloped virus with S-Protein);and its variants and mutants in the future

Corona Virus family has got more infectious and deadly with successive mutation in the last 17 years underscoring the importance of a device like Shycocan

Human Coronavirus OC4 (HCoV-OC43)

Common Cold and L. Respiratory track

infectionFour genotypes

Human Coronavirus 229E (HCoV-229E)

Common Cold

Severe Acute Respiratory Syndrome

(SARS-CoV-1)Muscle Pain,

Headache, Fever Cough, Dyspnea,

PneumoniaGenotype A to D

Human coronavirus HKU1 (HCoV-HKU1)L. Respiratory Track

Infection, Pneumonia, Bronchiolitis, ARDS

Human coronavirus NL63 (HCoV-NL63)

Pneumonia, Bronchiolitis

Middle East Respiratory

Syndrome (MERS-CoVor HCoV-EMC/2012)Severe Respiratory

Illness Fever, Cough, Shortness of Breath

Severe Acute Respiratory Syndrome

2 COVID-19 (SARS-CoV-2)

Fever, Dry Cough, Tiredness, Shortness of Breath, Chest Pain,

Loss of Speech or Movement

151 October 2020

COVID-19 MERS

SARS

1950-2004 1965 April 2003 Early 2004

Late 2004Late 20122019

Future CoronavirusPandemics

Caused by similar positive senseS-Protein structure

It also disables the Influenza family of viruses that cause annual seasonal flu, Swine Flu, Bird Flu like Pandemics, and save millions of hours of lost productivity

Influenza A• H1N1 (Spanish Flu 1918 & Swine Flu

2009)• H2N2 (Asian Flu 1957)• H3N2 (Hong Kong Flu 1968)

• 3C.2a1, 3C.2a2, 3C.2a3, 3C.2a4 Seasonal Flus

• H5N1 (Bird Flu 2004, Seasonal Flu)• H7N7 (Unusual Zoonotic Potential)• H1N2 ((infects Pigs & Humans)• H9N2• H7N2 (Bird Flu Virus)• H7N3 • H10N7• H7N9 rated in 2018 as having the greatest

pandemic potential among the Type A subtypes

• H6N1 Infect Eurasian Teal

Influenza B• B (Victoria)

• V1A.1• V1A.2• V1A.3

• B (Yamagata)• Y1• Y2• Y3

Influenza C• Humans• Dogs• Pigs• Children

Influenza D• Pigs• Cattle

161 October 2020

Influenza (Flu) VirusesThere are two main types of influenza (flu) virus: Types A and B. The influenza A and B viruses that routinely spread in people (human influenza viruses) are responsible for seasonal flu epidemics each year. There are hundreds of variants of this family.

Source : CDC

Company profile of Shycocon Corporation Pte. Ltd.→ The company is the global licensee of Shycocan device for manufacturing, marketing,

sales and distribution of the device→Our company has subsidiaries across the globe. The India subsidiary is Shycocare

Technologies→We are investing a global infrastructure for enterprise support considering the importance

of the device in the coming years→A global manufacturing and supply chain is being set-up across all the continents→The Chairman of the company is Dr. Rajah Vijay Kumar the inventor of Shycocan device

and holder of more than 30 patents→The promoting and management team of the company has worked across Indian and

global multinationals→We are developing the best of breed partners and system integrators across the globe to

service both enterprise customer, MSME

171 October 2020

Specification sheet of Shycocan

191 October 2020

FAQ on Shycocan

New Category - Viral Attenuation Device

FAQ on Shycocan

→Who is the inventor of Shycocan?

→ Shycocan device has been invented Dr. Rajah Vijaykumar, an Indian Scientist with over 30 multi-disciplinary patents.Dr. Kumar is first a humanitarian and maintains a very low profile despite his prolific inventions. He is also theinventor of Cytotron which currently is approved for two medical applications, one to stop the growth cancer cells ina tumor, and second to repair & grow the skeletal tissue.

→ How long did it take to design the Shycocan and when was it built?

→ Dr. Rajah Vijaykumar developed a highly specialized alloy over five years of research while working on another patentwhich produces Photon rays of high intensity that emit electrons on striking solid surfaces. In early 2018 Bird Flu ledto culling of millions of chickens making many poultry farmers bankrupt. Dr. Kumar decided to build a machine usingthis alloy to help the farmers. The device was installed at the Scalene campus. At the end of 2018, it was observedthat the incidence of seasonal flu had reduced by 90% amongst the employees. When the current COVID-19pandemic struck in late 2019/ early 2020, the same machine was sent for certification and christened as “Shycocan’testing to global laboratory and found to be equally effective against COVID-19 virus.

→ Shycocan was not designed hurriedly post the COVID-19 pandemic but was already working and further refined basedon the feedback from testing laboratories and certification authorities over the last few months. Hence, it is welldesigned device that is effective, safe and has been thoroughly tested

FAQ on Shycocan

→What are the test conducted and certifications available for Shycocan?

→ The device has undergone extensive safety and virology tests and has received the CE approval from European Union

and shall be soon marketed in the US under the “Enforcement Discretion” of the FDA’s guidance during the COVID-19

Pandemic/ Public Health Emergency. It has passed all safety and emission tests related to these certifications, conducted

by UL. Based on the Virucidal Activity Test conducted the device disables/ attenuates 99.9% of the COVID-19 virus.

→ How does Shycocan work ?

→ COV-SARS2 virus is a positive sense virus with Spike Protein (S-Protein) that infects the human cell which has a negative

cellular membrane potential due to opposite charge polarity through the ACE2 receptor present in the cell. The

Shycocan device emits high intensity Photons that release electrons on striking solid surfaces. These electrons form an

electron cloud in the indoor space which neutralizes the positive charge on the S-Protein of the virus making it incapable

of infecting another person. This process is called “Attenuation” of the virus. It does this in safe a manner without any

harmful effect, radiation, ozone emission or toxicity to humans or the environment.

→ Does Shycocan kill the Corona Virus?

→ Shycocan does not kill the virus. It only disables/ attenuates the virus due to the unique action of neutralizing its charge

on the Spike Protein (S-Protein).

FAQ on Shycocan

→ What are the diseases against which Shycocan is effective?

→ Apart from COVID-19 virus, Shycocan attenuates the full spectrum of viruses belonging to the Corona and Influenza family. These virusesare enveloped with S-Protein which gets disables by electrons.

→ The Coronavirus family of viruses cause Pneumonia, Bronchiolitis, ARDS, MERS, SARS & COVID-19; and the Influenza family of virusescause annual seasonal flus, Swine Flu, Bird Flu and many other varieties of viral flu.

→ It shall also protect from future pandemics caused by variants or mutants of these viruses.

→ Does Shycocan affect bacteria, fungi and other microbes?

→ Shycocan does not affect any bacteria, fungi or other microbes other than the Corona and Influenza family of viruses. This is verycritical to maintain a balance of microbes in the environment, as a very sanitized environment shall increase toxicity andcompromise the immune system of humans. This may lead to many larger health complications in the coming years withreduced immunity.

→ Does Shycocan emit Photons or Electrons?

→ The Shycocan device produced Photons through a specialized alloy. The photons emit electrons on contact with solid surfaceslike furniture, walls etc. Hence, the whole action is termed as Photon Emitted Electron Emission.

→ Does the Shycocan device work indoor and/or outdoor?

→ Shycocan device is designed to work effectively in an indoor space. It may be partially effective in the outdoor space in an areaswhere the photon rays strike directly. It may not provide adequate protection in the larger outdoor area.

FAQ on Shycocan→What is the procedure to setup a Shycocan? Where should I place my Shycocan (s)?

→ Shycocan is a plug and play device that just needs to be switched ON. It is plugged into a standard A/C outlet. Theinstallation is recommended to be done on a wall stand provided with the device. The placement of the device isrecommended at a height of 7 feet or above on the wall next to one of the corners of the room pointing diagonallytowards to the opposite corner of the room and a few degrees downwards. This allows the maximum coverage of theroom for protection.

→ In case there are multiple Shycocan devices installed in a larger area they should be placed at equal distance or in thecorners of the room. They are also recommended to be installed on opposite walls for coverage on both sides of theroom. It is best to seek professional help from Shycocan Corporation prior to planning for the installation.

→What is the coverage area of a Shycocan device?

→ The first model launched for the Shycocan device covers an area of 10,000 cub feet or 1,000 sq feet for a space with aroof of 10 feet. Multiple devices may be installed for larger spaces and placed as per the recommendation of our trainedservice professionals.

→ The next model due for launch in expected in 3-4 months and shall cover the area of 100,000 cubic feet or 10,000 sqfeet. The new device shall be meant for larger spaces like auditoriums, high roof enclosures, airports etc.

→Will a single Shycocan protect my entire house/establishment?

→ One device only covers one room upto 1000 square feet. It does not cover an area outside the indoor space where it isinstalled even if the room size is much smaller or has a glass partition. For example, if one needs protection in tworooms each of 300 square feet, two individual devices shall be required, one for each room.

FAQ on Shycocan

→What are the application the device?

→ The device may be deployed safely in all environments both large or small enclosed spaces. It helps create 'safer zones'in hospitals, clinics, homes, retail stores, restaurants & hotels, schools & colleges, places of worship, residential,commercial building, industrial and sporting environments.

→ Does the effectiveness of Shycocan reduce if the number of people in the given area increases?

→ It is recommended that people maintain reasonable distance, avoid body contact and not overcrowd the indoor space.There is need to allow the Photon rays to cover the whole room and provide protection by releasing electrons thatneutralize the virus. e.g. a conference room with normal seating would be safe to operate. However, in case people arein a function or leaving the cinema hall, a space of 2-3 feet is advised between various inhabitants.

→ How do I know if my Shycocan is working effectively?

→ A indicator light in front panel of the device shows that it is working.

→ Further, a simple test of using a CFL bulb or a tube light held close the device shall suffice. It glows indicating emission ofPhoton mediated electrons. However, in more complex environments like cinema halls, hospitals, malls etc., our trainedprofessionals shall check the density of electrons using an oscilloscope. Based on the readings it can be determined ifthere is enough safety and protection from the transmission of the COVID-19 virus in all areas of the closed space.

FAQ on Shycocan

→Does Shycocan cure a COVID-19 affected patient?

→ Shycocan does not help to cure patients that has already tested positive for COVID-19. The patient needs to be undercare of a certified medical practitioner. However, Shycocan can stop the transmission of the virus from the patient toother people not infected by the virus in the closed space where the device is installed.

→ How long does the effect of Shycocan last?

→ Shycocan needs to be continuously kept operational to provide protection against the transmission of the COVID-19virus in the closed space. It is recommended that power back-up is installed to ensure that it does not stop workingduring any power failure.

→ Are there any side-effects of the Shycocan device on humans, other living beings or the environment?

→ Shycocan does not have any known side effect on humans, living organisms, plants or the environment. All the relevanttests related to the environmental safety as prescribed by CE certification were carried out by UL (leading testing labs inthe world), and it was determined that the device meets all safety standards. Further, it does not generate any Ozone,which may damage human lungs. Every Shycocan is test for absence of Ozone before dispatch from the manufacturinglocation.

→ Are there any medical ailments, people suffering from which should avoid using the Shycocan device?

→ There are no known side-effects of Shycocan device on people suffering from any ailment. It is considered safe andhighly recommended to be used to protect patients of any other medical ailments from contracting COVID-19 as theymay already have depressed immune system due to other ailments.

FAQ on Shycocan→What is the possibility of a person exposed to Shycocan contracting Covid-19 once he/she moves beyond the device reach?

→ Shycocan only provides protection in the indoor space where it is installed. Once the person leaves that indoor spacewhere the device is installed, they need taken precautions as advised by WHO guidelines.

→ Can the photon rays emitted from Shycocan contaminate food/water?

→ Shycocan is safe to food, water and the environment. Photon rays emitted from the Shycocan does not contaminatefood, water or the environment.

→ Can I open my windows in a room where a Shycocan is running?

→ You can open the windows while the Shycocan is running for circulation of air. However, it is advisable to keep the wiremesh or curtains closed so that an electron cloud may be formed in the room

→What maintenance is required for a Shycocan(s)?

→ Shycocan needs cleaning in the front plate to maintain the air-cirulation. This can be done by the customer. It does notrequire change of consumables or any other part on a periodic basis. However, in case the part fails the part is replacedby our organization at our repair facility.

→ How many hours should I keep it on? What is the electricity consumption?

→ The device is designed for continuous use. it is recommended to be kept ON 24/7 or prior to the closed space being usedits inhabitants. The power consumption of the device is 30 W.

2020 October 1

������SRK Supplies LLC

Post Box No 236294 Dubai - UAE Tel : 04 - 2639833 / 04 - 3383717 Email : [email protected] Website : www.srksupplies.com

Authorized Dealer

Ashley Coutinho
Ashley Coutinho
Ashley Coutinho